Lothar H. Finke
Corporate Officer/Principal at INCYTE CORPORATION
Profile
Lothar H.
Finke's career history includes current and former positions as well as his education.
Currently, he is the Group Vice President & General Manager at Incyte Corp.
Previously, he worked as a Principal at Merck KGaA from 1995 to 2004 and as the Chief Medical Officer at Argos Therapeutics, Inc. from 2004 to 2009.
He also held positions as a Principal at Lexigen Pharmaceuticals Corp.
and EMD Pharmaceuticals, Inc. Additionally, he worked as a Principal at the Basel Institute for Immunology from 1993 to 1994.
Dr. Finke obtained a doctorate degree from Philipps University of Marburg.
Lothar H. Finke active positions
| Companies | Position | Start |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 2017-05-31 |
Former positions of Lothar H. Finke
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2009-01-31 |
| MERCK KGAA | Corporate Officer/Principal | 2004-06-30 |
| Basel Institute for Immunology | Corporate Officer/Principal | 1993-12-31 |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Corporate Officer/Principal | - |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Corporate Officer/Principal | - |
Training of Lothar H. Finke
| Philipps University of Marburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| MERCK KGAA | Health Technology |
| Private companies | 3 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
- Stock Market
- Insiders
- Lothar H. Finke
